Onkos Surgical Celebrates Patient Experience Week

In celebration of Patient Experience Week (April 26-30, 2021), Onkos Surgical, an innovator of solutions for musculoskeletal oncology and complex orthopedic procedures, has announced ongoing growth and adoption of its patient-centric innovations.
 
These solutions are designed to help improve patient outcomes and experiences using the latest in precision anatomic modeling, 3D printing, design innovation, and workflow optimization. All are intended to help address the clinical challenges of individual surgeons and patients with these complex orthopedic conditions.
 
Last year alone, Onkos launched three new solutions that build upon its innovations in implant design and pre-op planning — the ELEOS Proximal Femoral Replacement, the ELEOS Proximal Tibia with BioGrip, and uDesign on Demand for personalized surgical planning. Onkos also launched its BioGrip technology, the first-of-its-kind for limb salvage, which supports soft tissue in-growth through its novel 3D-printed porous structure.
 
“Onkos was founded on the principle that cancer patients deserve solutions designed specifically for them. Everything we do focuses on eliminating surgical complexity and improving the patient and surgeon experience and outcome. We are now expanding the lessons learned in musculoskeletal oncology to highly complex orthopaedic challenges where our approach, precision, and technology are aiming to make a significant difference,” said Patrick Treacy, co-founder and CEO of Onkos Surgical. “We are honored to be able to serve patients, surgeons, and care teams every single day, and are proud of how our approach to innovation is being adopted by surgeons looking to bring the best to their patients.”
 
Working closely with surgeons, Onkos provides precise pre-operative planning support coupled with precise reconstructive solutions and workflow optimization. Its orthopedic approach has helped save over 2,000 limbs.
 
“Facing bone cancer surgery or a complex orthopedic surgery is an intimidating and potentially life-changing experience for patients,” said Steven Gitelis, MD, Onkos Surgical chief medical officer, Rush Medical College Endowed professor and chief of the musculoskeletal oncology program at Rush Cancer Center. “Not only are our innovations supporting surgeons, but they are also helping to ensure we minimize bone loss, restore function, and experience better healing of bone and soft tissues.”